Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/1999
10/06/1999EP0946164A1 Integrin antagonists
10/06/1999EP0946147A1 Treatment of equine laminitis
10/06/1999EP0839133B1 4,9-ethano-benzo(f)isoindole derivatives as farnesyl transferase inhibitors
10/06/1999EP0584068B1 Method and composition for ameliorating the adverse effects of aging
10/06/1999CN1230962A 3-substituted pyrido [4',3' : 4, 5] thieno [2,3-D] pyrimidine derivatives, their preparation and their use
10/06/1999CN1230956A Method of producing polyphenol-containing compositions
10/06/1999CN1230891A Lectin compositions and uses thereof
10/06/1999CN1230889A Naaladase compositions and methods for treating glutamate abnormality and effecting neuronal activity in animals
10/06/1999CN1230884A Thiol sulfone metalloprotease inhibitors
10/06/1999CN1230875A Flavonol containing food supplements
10/05/1999US5962701 Heat and oxidation resistance; photostability
10/05/1999US5962695 Aromatic amidine derivatives and salts thereof
10/05/1999US5962682 Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists
10/05/1999US5962536 Injectable propofol formulations
10/05/1999US5962531 5-aroylnaphthalene derivatives as anti-inflammatory agents
10/05/1999US5962529 Metalloproteinase inhibitors
10/05/1999US5962521 Prostate glands disorders
10/05/1999US5962513 Central nervous system, psychological disorders
10/05/1999US5962509 Dithiolylidene acetamide derivatives
10/05/1999US5962504 Activator of protein kinase; anticancer agent
10/05/1999US5962503 Use of cholinesterase inhibitors in the treatment of xerostomia
10/05/1999US5962496 Central nervous system disorders
10/05/1999US5962495 Estrogen sensitive diseases; breast cancer; prostate tumors
10/05/1999US5962492 Antiasthma agents; antiinflammatory agents
10/05/1999US5962490 Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
10/05/1999US5962486 Headache therapy
10/05/1999US5962485 N-(2-benzyloxy-1-phenethyl)-N-(2'-methoxyethyl)amino-methane compounds are useful as tachykinin antagonists
10/05/1999US5962483 Antiasthma agents; antiinflammatory agents
10/05/1999US5962475 Osteoporosis, restenosis, breast cancer
10/05/1999US5962474 Analgesics; headaches
10/05/1999US5962472 Alzheimer's, parkinson, huntington diseases; amyotropic laterial sclerosis; nervous system disorders
10/05/1999US5962471 Substituted 6- and 7-aminotetrahydroisoquinolinecarboxylic acids
10/05/1999US5962465 Brain disorders; psychological disorders
10/05/1999US5962464 Side effect reduction
10/05/1999US5962458 Angiogenesis inhibitors, anticancer agents, antidiabetic agents, skin disorders, autoimmune diseases, antiinflammatory agents, vision defects
10/05/1999US5962457 2,3 Disubstituted- (5,6)-heteroarylfused-pyrimidine-4-ones
10/05/1999US5962455 Eating disorders, cardiovascular disorders, hypotensive agents
10/05/1999US5962451 Gastrointestinal disorders; antiulcer agent; anticancer agents; side-effect reduction
10/05/1999US5962450 Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines and their use as medicaments
10/05/1999US5962447 Psychological disorders, cognition activators, schizophrenia
10/05/1999US5962446 Administering protein kinase inhibitors
10/05/1999US5962444 Hormone inhibitor; hormone replacement therapy
10/05/1999US5962439 Cardiovascular disorder
10/05/1999US5962437 Hepatitis, herpes and aida virus
10/05/1999US5962427 Targeting, transferring dna into mammalian repair cells
10/05/1999US5962422 Inhibition of selectin binding
10/05/1999US5962416 Somatotropin releasing compound for accelerating hoof growth in horses
10/05/1999US5962411 Human growth hormone variants and methods of administering same
10/05/1999US5962410 Fungicides, antiprotozoa agent
10/05/1999US5962405 Storage-stable fibrinogen preparations
10/05/1999US5962303 The invention relates to polynucleotides and polypeptides of bacterial ?topoisomerase iii.?
10/05/1999US5962265 A polypeptide is described which is expressed at a particularly high level in tissues of the human immune system.
10/05/1999US5961981 Biologically-active compositions extracted from dictyotales plant family
10/05/1999US5960792 Device for aerosolized delivery of peptide drugs
10/05/1999CA2195924C 3-aza and 3-oxa-piperidone tachykinin antagonists
10/05/1999CA2189534C Imidazole derivatives and processes for the preparation thereof
10/05/1999CA2175204C Certain fused pyrrolecarboxanilides; a new class of gaba brain receptor ligands
10/05/1999CA2009902C Heterocycles
09/1999
09/30/1999WO1999049858A1 Utilization of alkyl hydrogen fumerates for treating psoriasis, psoriatic arthritis, neurodermatitis and regional enteritis
09/30/1999WO1999049316A2 Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer
09/30/1999WO1999049027A1 Methods for prevention and treatment of cancer
09/30/1999WO1999049023A1 The cytokine family member 2-21
09/30/1999WO1999049018A1 Glycosyl sulfotransferase-3
09/30/1999WO1999049015A2 Cardiac-derived stem cells
09/30/1999WO1999048910A1 Use of inhibitors of mammalian asparaginyl endopeptidase for therapy of autoimmune disease
09/30/1999WO1999048892A1 Pyrazolo-pyridine derivatives as ligands for gaba receptors
09/30/1999WO1999048891A1 1-(3-heteroarylpropyl- or -prop-2-enyl)-4-benzylpiperidines used as nmda receptor antagonists
09/30/1999WO1999048888A1 Imidazolone anorectic agents: ii. phenyl derivatives
09/30/1999WO1999048887A1 Imidazolone anorectic agents: iii. heteroaryl derivatives
09/30/1999WO1999048881A1 Metalloproteinase inhibitors
09/30/1999WO1999048879A1 Thiocarboxamide derivatives and their use as inhibitors of alpha-4 integrins
09/30/1999WO1999048873A1 Imidazolone anorectic agents: i. acyclic derivatives
09/30/1999WO1999048871A1 Pyridine derivative and pharmaceutical containing the same
09/30/1999WO1999048868A2 Heterocyclic classes of compounds for the modulating tyrosine protein kinase
09/30/1999WO1999048858A2 Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents
09/30/1999WO1999048537A1 Use of scatter factor to enhance angiogenesis
09/30/1999WO1999048535A1 Formulations for protection of peg-interferon alpha conjugates
09/30/1999WO1999048533A1 An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition
09/30/1999WO1999048527A1 Apo-2 ligand-anti-her-2 antibody synergism
09/30/1999WO1999048523A2 Antagonists of the inflammatory mediator oncostatin m (osm)
09/30/1999WO1999048522A1 Pharmaceutical composition containing a cysteine protease inhibitor for prophylaxis and therapy of brain tissue impairment
09/30/1999WO1999048521A1 Sciellin and uses thereof
09/30/1999WO1999048508A1 Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms
09/30/1999WO1999048507A2 Steroidal saponins for treating alzheimer's disease
09/30/1999WO1999048503A1 Antitumor composition containing a synergistic combination of an anthracycline derivative with a camptothecin derivate
09/30/1999WO1999048496A1 Therapy of estrogen-associated disorders
09/30/1999WO1999048495A1 Benzoates derivatives for inhibiting angiogenesis
09/30/1999WO1999048494A1 Sustained-release composition of oxybutynin with reduced xerostomia effect
09/30/1999WO1999048488A2 Methods for decreasing beta amyloid protein
09/30/1999WO1999048484A2 Use of cabergoline in the treatment of restless legs syndrome
09/30/1999WO1999048482A2 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease
09/30/1999WO1999042465A3 Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation
09/30/1999WO1999041411A3 Method for diagnosis and treatment of disorders of carbohydrate metabolism
09/30/1999WO1999037325A3 Method for treating acute intermittent porphyria (aip) and other porphyric diseases
09/30/1999WO1999032449A3 Benzazine derivatives as phosphodiesterase 4 inhibitors
09/30/1999WO1999029308A3 Method for combating obesity
09/30/1999WO1999006340A3 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors
09/30/1999CA2326053A1 Use of scatter factor to enhance angiogenesis
09/30/1999CA2325943A1 Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents
09/30/1999CA2325935A1 Heterocyclic families of compounds for the modulation of tyrosine protein kinase
1 ... 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 ... 1564